Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-22Open-label, Flexible-dose Adjunctive Bromocriptine for Patients With Schizophrenia and Prediabetes
-
CLINICAL_TRIALS study record update · 2025-09-19Comparison of the Effects of Aerobic Exercise and Computerized Cognitive Stimulation in Patients With Schizophrenia - A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-09-19Crossover Bioequivalence Study of 12 mg VHX-896 and Iloperidone Tablets Under Steady-State Conditions
-
CLINICAL_TRIALS study record update · 2025-09-19rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-18Real-time fMRI Neurofeedback as a Tool to Mitigate Auditory Hallucinations in Patients With Schizophrenia - R33 Phase
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-18Efficacy And Safety of BXCL501 Evaluated For At-Home Use In A Multisite Double-Blind Placebo-Controlled Trial For Agitation Associated With Schizophrenia And Bipolar Disorder
-
CLINICAL_TRIALS study record update · 2025-09-18Horyzons: Implementation and Integration in Clinical Practice
-
CLINICAL_TRIALS study record update · 2025-09-17A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Two Fixed Doses (10 mg and 30 mg QD) of CVL-231 (Emraclidine) in Participants With Schizophrenia Experiencing an Acute Exacerbation of Psychosis
-
CLINICAL_TRIALS study record update · 2025-09-17Sex Differences in NMDA-enhancing Treatment of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-17An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in De Novo Subjects With DSM-5 Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-15The Effect of an Individual Empowerment Program Applied to Primary Caregivers of Patients Diagnosed With Schizophrenia on the Burden of Care, Psychological Well-being, and Self-efficacy: A Randomized Controlled Experimental Study
-
CLINICAL_TRIALS study record update · 2025-09-15Comparison of the Effects of Physical Activity and Virtual Reality Training on Physical Function, Cognition and Quality of Life in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-15A Multi-Center, Randomized, Double-Blind, Parallel-Design, Exploratory Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-11Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity
-
CLINICAL_TRIALS study record update · 2025-09-10Phase II, Double Blind, Randomized, Placebo Controlled, Parallel Group, Trial to Explore Efficacy, Safety and Pharmacokinetics of CPL500036 (PDE10A Inhibitor) in Patients With an Acute Exacerbation of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-10Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
-
CLINICAL_TRIALS study record update · 2025-09-08A Single Ascending Dose Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Single Intramuscular Injection of Quarterly Risperidone (QUAR) for Different Formulations and Dose Strengths in Participants With Schizophrenia (QUARTZ Study)
-
CLINICAL_TRIALS study record update · 2025-09-05Young Adults With Violent Behavior During Early Psychosis: An Open Pilot Trial
-
CLINICAL_TRIALS study record update · 2025-09-05Visual Remediation in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-05Energetics and Glutamate in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-04Evaluation of Efficacy and Safety of Paliperidone Among People With Schizophrenia in Bangladesh
-
CLINICAL_TRIALS study record update · 2025-08-29Causal Role of Medial Prefrontal Neural Activity in Self-Agency in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-08-24A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-08-22Assessment of ERG Components to Discriminate Between Schizophrenia and Bipolar Disorder Type I
-
CLINICAL_TRIALS study record update · 2025-08-22A Phase 2B Randomized, Double-Blind, Placebo- and Active-Controlled Trial of the Efficacy and Safety of MK-8189 in Participants Experiencing an Acute Episode of Schizophrenia